• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FSTL1 通过抑制 NF-κB 通路增加上皮性卵巢癌细胞对顺铂的敏感性。

FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.

机构信息

Department of Gynecology, The Fourth Hospital of Hebei Medical University, No. 12, Jiankang Road, Shijiazhuang, 050011, Hebei, China.

出版信息

Cancer Chemother Pharmacol. 2021 Mar;87(3):405-414. doi: 10.1007/s00280-020-04215-9. Epub 2021 Jan 3.

DOI:10.1007/s00280-020-04215-9
PMID:33392640
Abstract

OBJECTIVE

To investigate the effects of FSTL1-mediated NF-κB signaling pathway on cisplatin (DDP) sensitivity of EOC cells.

METHODS

FSTL1 expression was determined in epithelial ovarian cancer (EOC) tissues and corresponding adjacent tissues using immunohistochemistry. SKOV3 and SKOV3/DDP cells were transfected and grouped into Blank, Vector, and FSTL1 groups. The sensitivity and 50% inhibitory concentration (IC50) of cells treated with different concentrations of DDP were detected by MTT assay. SKOV3/DDP cells were treated with 20 μM DDP, followed by evaluation of cell proliferation, cell apoptosis and determination of NF-κB pathway-related proteins while SKOV3 cells without.

RESULTS

FSTL1 expression in EOC tissues and cells was significantly down-regulated, especially decreased in DDP-resistant EOC cells SKOV3/DDP. In SKOV3 cells and SKOV3/DDP cells, the cell viability was reduced and the DDP sensitivity was improved with the decreased IC50 after over-expressing FSTL1. Compared with Blank group, FSTL1 group had declined number of SKOV3 cell colonies and increased cell apoptosis, with obvious up-regulations of FSTL1, Bax/Bcl-2 and cleaved caspase-3 expression and the down-regulations of p-IκBα, p-p65 and survivin expression. Combination of up-regulation of FSTL1 and DDP treatment can also effectively reduce cell colony forming, increase cell apoptosis, and inhibit NF-κB pathway activity of SKOV3/DDP cells. Moreover, this combination can also significantly suppress the growth of subcutaneous xenograft tumors in nude mice.

CONCLUSION

FSTL1 may inhibit NF-κB signaling pathway to suppress the growth and promote the apoptosis of epithelial ovarian cancer cells, and thereby enhancing its DDP sensitivity.

摘要

目的

探讨 FSTL1 介导的 NF-κB 信号通路对顺铂(DDP)敏感性的影响。

方法

采用免疫组织化学法检测上皮性卵巢癌(EOC)组织及相应癌旁组织中 FSTL1 的表达。转染 SKOV3 和 SKOV3/DDP 细胞,分为空白组、载体组和 FSTL1 组。采用 MTT 法检测不同浓度 DDP 处理细胞的敏感性和半数抑制浓度(IC50)。用 20 μM DDP 处理 SKOV3/DDP 细胞,评估细胞增殖、细胞凋亡情况,并测定 NF-κB 通路相关蛋白。而 SKOV3 细胞不做处理。

结果

EOC 组织和细胞中 FSTL1 的表达明显下调,尤其是在 DDP 耐药的 EOC 细胞 SKOV3/DDP 中。在 SKOV3 细胞和 SKOV3/DDP 细胞中,过表达 FSTL1 后细胞活力降低,IC50 降低,DDP 敏感性提高。与空白组相比,FSTL1 组 SKOV3 细胞集落数量减少,细胞凋亡增加,FSTL1、Bax/Bcl-2 和 cleaved caspase-3 表达上调,p-IκBα、p-p65 和 survivin 表达下调。上调 FSTL1 与 DDP 联合处理还能有效降低 SKOV3/DDP 细胞集落形成,增加细胞凋亡,抑制 NF-κB 通路活性。此外,该联合处理还能显著抑制裸鼠皮下移植瘤的生长。

结论

FSTL1 可能通过抑制 NF-κB 信号通路抑制上皮性卵巢癌细胞的生长,促进其凋亡,从而增强其对 DDP 的敏感性。

相似文献

1
FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.FSTL1 通过抑制 NF-κB 通路增加上皮性卵巢癌细胞对顺铂的敏感性。
Cancer Chemother Pharmacol. 2021 Mar;87(3):405-414. doi: 10.1007/s00280-020-04215-9. Epub 2021 Jan 3.
2
[Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].[亚甲基四氢叶酸还原酶(MTRR)基因对多药耐药性上皮性卵巢癌凋亡和自噬途径的影响]
Zhonghua Fu Chan Ke Za Zhi. 2016 Apr 25;51(4):285-92. doi: 10.3760/cma.j.issn.0529-567X.2016.04.008.
3
[Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer].[上皮性卵巢癌铂耐药裸鼠模型的建立及生物学特性]
Zhonghua Fu Chan Ke Za Zhi. 2014 Jul;49(7):523-30.
4
miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells.miR-874-3p 通过调节上皮性卵巢癌细胞中 NF-κB/凋亡抑制蛋白信号通路来减轻顺铂耐药性。
Mol Cell Biochem. 2022 Jan;477(1):307-317. doi: 10.1007/s11010-021-04271-6. Epub 2021 Oct 30.
5
[Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].[下调MTRR基因对顺铂耐药卵巢癌SKOV3细胞的生物学效应的体外及体内研究]
Zhonghua Fu Chan Ke Za Zhi. 2016 Feb;51(2):126-34. doi: 10.3760/cma.j.issn.0529-567X.2016.02.009.
6
Tasquinimod enhances the sensitivity of ovarian cancer cells to cisplatin by regulating the Nur77-Bcl-2 apoptotic pathway.他卡西醇增强卵巢癌细胞对顺铂的敏感性通过调节 Nur77-Bcl-2 凋亡通路。
Adv Clin Exp Med. 2024 Feb;33(2):151-161. doi: 10.17219/acem/166044.
7
TRIAP1 Inhibition Activates the Cytochrome c/Apaf-1/Caspase-9 Signaling Pathway to Enhance Human Ovarian Cancer Sensitivity to Cisplatin.三磷酸腺苷结合盒转运蛋白 A1 抑制剂激活细胞色素 c/Apaf-1/半胱天冬酶-9 信号通路增强人卵巢癌细胞对顺铂的敏感性。
Chemotherapy. 2019;64(3):119-128. doi: 10.1159/000501633. Epub 2019 Oct 29.
8
Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.可溶性CD40配体使上皮性卵巢癌细胞对顺铂治疗敏感。
Biomed Pharmacother. 2016 Apr;79:166-75. doi: 10.1016/j.biopha.2016.01.006. Epub 2016 Feb 26.
9
The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.强力霉素对顺铂敏感及耐药的上皮性卵巢癌的抑制作用。
PLoS One. 2014 Mar 5;9(3):e89841. doi: 10.1371/journal.pone.0089841. eCollection 2014.
10
Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.那可丁通过调控细胞周期和激活凋亡途径增加耐药卵巢癌细胞系SKOV3/DDP对顺铂的敏感性。
Cell Biochem Biophys. 2015 May;72(1):203-13. doi: 10.1007/s12013-014-0438-y.

引用本文的文献

1
Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma.齐墩果酸衍生物K73-03诱导肝癌细胞凋亡的机制研究
Cancer Cell Int. 2024 Jan 7;24(1):17. doi: 10.1186/s12935-023-03119-x.
2
RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.RUNX1 敲低诱导高级别浆液性卵巢癌细胞凋亡和 EMT 受损。
J Transl Med. 2023 Dec 6;21(1):886. doi: 10.1186/s12967-023-04762-8.
3
Analysis of the expression and mechanism of follistatin‑like protein 1 in cervical cancer.

本文引用的文献

1
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation.FSTL1 通过 miR-137 调控的整合素 β3/Wnt 信号增强乳腺癌细胞的化疗耐药性并维持其干性。
Cancer Biol Ther. 2019;20(3):328-337. doi: 10.1080/15384047.2018.1529101. Epub 2018 Oct 18.
2
Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.NF-κB 的抑制可通过下调 MGMT 基因表达发挥抗胶质瘤活性并降低替莫唑胺诱导的化疗耐药性。
Cancer Lett. 2018 Aug 1;428:77-89. doi: 10.1016/j.canlet.2018.04.033. Epub 2018 Apr 27.
3
分析在宫颈癌中卵泡抑素样蛋白 1 的表达和作用机制。
Oncol Rep. 2023 Dec;50(6). doi: 10.3892/or.2023.8652. Epub 2023 Oct 27.
4
RUNX1-Regulated Signaling Pathways in Ovarian Cancer.RUNX1调控的卵巢癌信号通路
Biomedicines. 2023 Aug 23;11(9):2357. doi: 10.3390/biomedicines11092357.
5
H3K27 acetylation-induced FSTL1 upregulation by P300/RUNX1 co-activation exacerbated autophagy-mediated neuronal damage and NF-κB-stimulated inflammation in Alzheimer's disease.P300/RUNX1共激活导致的H3K27乙酰化诱导FSTL1上调,加剧了阿尔茨海默病中自噬介导的神经元损伤和NF-κB刺激的炎症反应。
Cytotechnology. 2023 Oct;75(5):449-460. doi: 10.1007/s10616-023-00589-9. Epub 2023 Aug 4.
6
CARD9 contributes to ovarian cancer cell proliferation, cycle arrest, and cisplatin sensitivity.CARD9 促进卵巢癌细胞增殖、周期阻滞和铂类药物敏感性。
BMC Mol Cell Biol. 2022 Nov 28;23(1):49. doi: 10.1186/s12860-022-00447-0.
7
Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings.二甲双胍提高卵巢癌对紫杉醇和铂类药物的敏感性:体外研究结果综述。
Int J Mol Sci. 2022 Oct 25;23(21):12893. doi: 10.3390/ijms232112893.
8
Cisplatin for cancer therapy and overcoming chemoresistance.用于癌症治疗及克服化疗耐药性的顺铂。
Heliyon. 2022 Sep 14;8(9):e10608. doi: 10.1016/j.heliyon.2022.e10608. eCollection 2022 Sep.
9
Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription.奇数跳跃相关 1 通过促进卵泡抑素样蛋白 1 转录在卵巢癌中发挥肿瘤抑制作用。
Hum Cell. 2022 Nov;35(6):1824-1837. doi: 10.1007/s13577-022-00767-5. Epub 2022 Aug 14.
10
Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells.烟碱型受体调节三阴性乳腺癌细胞中的抗肿瘤治疗反应。
World J Clin Oncol. 2022 Jun 24;13(6):505-519. doi: 10.5306/wjco.v13.i6.505.
miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1.
miR-98-5p 通过靶向 Dicer1 抑制 miR-152 的生成从而促进上皮性卵巢癌对顺铂的耐药性。
Cell Death Dis. 2018 May 1;9(5):447. doi: 10.1038/s41419-018-0390-7.
4
Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells.阻断核因子-κB(NF-κB)通路抑制耐药卵巢癌细胞的生长并诱导其凋亡。
Int J Biochem Cell Biol. 2018 Jun;99:1-9. doi: 10.1016/j.biocel.2018.03.015. Epub 2018 Mar 19.
5
Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.卵泡抑素样蛋白1在透明细胞肾细胞癌中发挥肿瘤抑制作用。
Chin J Cancer. 2018 Jan 22;37(1):2. doi: 10.1186/s40880-018-0267-2.
6
FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer.FSTL1 抑制非小细胞肺癌肿瘤细胞的增殖、侵袭和存活。
Oncol Rep. 2018 Jan;39(1):13-20. doi: 10.3892/or.2017.6061. Epub 2017 Oct 31.
7
Effects of FSTL1 on cell proliferation in breast cancer cell line MDA‑MB‑231 and its brain metastatic variant MDA‑MB‑231‑BR.FSTL1 对乳腺癌细胞系 MDA-MB-231 及其脑转移变体 MDA-MB-231-BR 细胞增殖的影响。
Oncol Rep. 2017 Nov;38(5):3001-3010. doi: 10.3892/or.2017.6004. Epub 2017 Sep 26.
8
FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk.FSTL1 通过 NFκB-BMP 信号串扰促进食管鳞癌转移和化疗耐药。
Cancer Res. 2017 Nov 1;77(21):5886-5899. doi: 10.1158/0008-5472.CAN-17-1411. Epub 2017 Sep 7.
9
FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinoma.在肝细胞癌中,FSTL1通过以一种AKT/GSK - 3β依赖性方式减弱细胞凋亡来促进肿瘤进展。
Cancer Biomark. 2017 Jul 19;20(1):75-85. doi: 10.3233/CBM-170132.
10
Downregulation of miR-429 contributes to the development of drug resistance in epithelial ovarian cancer by targeting ZEB1.miR-429的下调通过靶向ZEB1促进上皮性卵巢癌耐药性的发展。
Am J Transl Res. 2017 Mar 15;9(3):1357-1368. eCollection 2017.